Stock Taper
Lite Strategy, Inc., formerly MEI Pharma, is a San Diego-based clinical-stage pharmaceutical company developing innovative cancer therapies since 2000.

Lite Strategy, Inc. (LITS), formerly MEI Pharma, is the first U.S. publicly traded company to hold Litecoin as its primary treasury reserve asset, providing investors institutional-grade exposure to digital assets through its stock.
Overall rating: B-
| PEER | PRICE | |
|---|---|---|
RLMD | $4.33 | COMPARE |
IMUX | $15.40 | COMPARE |
ACRV | $2.06 | COMPARE |
ACET | $9.06 | COMPARE |
XBIT | $2.27 | COMPARE |
PMVP | $1.22 | COMPARE |
NTRB | $4.46 | COMPARE |
TCRX | $0.75 | COMPARE |